Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

NCT07168993 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
2063
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

bioAffinity Technologies Inc.